03.21.24 -- Super Generics: Market Trends In Europe

When it comes to transporting highly sensitive and valuable materials, such as cell therapies, learn how teams can ensure that unique storage and distribution requirements are met.

See which process conditions and protocols were chosen as optimization targets in this case, and the resulting improvements to ADC production and purification that assessing these parameters provided.

Using a contract or toll manufacturer in the specialty and custom chemical industry can be viewed as a quality and supply chain risk. Discover equipment sourcing strategies that can mitigate those risks.

Explore results from a study evaluating the effects of different pore sizes on colony size and microbial recovery using membrane filters.

To meet ambitious orphan drug development timelines, CDMOs must be able to scale quickly to progress from early clinical development to validation and commercial launch.

See how the preventative approach an emerging biotech company took to mitigate risks and identify potential concerns before their FDA inspection and NDA submission ultimately led to success.

Finding an outsourcing partner capable of giving your company proper attention and meeting project milestones on schedule is crucial to ensuring patients in need receive treatment in a timely manner.

Gain insights into a “simul-spray” process pioneering for combining small and large molecules into a single, atomized drug product for inhalation administration.

A growing pharmaceutical/biotech company hired a global consulting firm for a project that required EMPQ services for qualification activities on a newly completed aseptic processing suite.

As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.

Often, a complication of feeding and batching is charging tanks/reactors of different heights and configurations. Discover a highly accurate feeding solution that can be moved from mixer to mixer.

Explore how a solvent-free alternative for the production of amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.